Organon & Co. OGN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 164.00M | 108.00M | 146.00M | -205.00M | 160.00M |
| Total Depreciation and Amortization | 82.00M | 80.00M | 86.00M | 96.00M | 92.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.00M | 44.00M | -49.00M | 284.00M | 39.00M |
| Change in Net Operating Assets | 102.00M | -125.00M | 42.00M | -34.00M | -27.00M |
| Cash from Operations | 370.00M | 107.00M | 225.00M | 141.00M | 264.00M |
| Capital Expenditure | -44.00M | -42.00M | -37.00M | -45.00M | -46.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | 0.00 | 0.00 | 433.00M | -- | -- |
| Other Investing Activities | 0.00 | -34.00M | -10.00M | -20.00M | -69.00M |
| Cash from Investing | -44.00M | -76.00M | 386.00M | -65.00M | -115.00M |
| Total Debt Issued | -- | -- | -- | 325.00M | 300.00M |
| Total Debt Repaid | 0.00 | 0.00 | -32.00M | -507.00M | -372.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -6.00M | -1.00M | -1.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.00M | -6.00M | -5.00M | -4.00M | -3.00M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.00M | -12.00M | -38.00M | -187.00M | -76.00M |
| Foreign Exchange rate Adjustments | 2.00M | -3.00M | -31.00M | 13.00M | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 323.00M | 16.00M | 542.00M | -98.00M | 73.00M |